FDA Clearance Tracker · P180025-S010
MANTA Vascular Closure Device, 14F, MANTA Vascular Closure Device, 18F, MANTA 8F Depth Locator, MANTA 14F Depth Locator
Last checked: Nov 20, 2026Latest source record: Oct 11, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Oct 11, 2023
Approved
Time to decision
271 days
Received Jan 13, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P180025-S010
- Device name
- MANTA Vascular Closure Device, 14F, MANTA Vascular Closure Device, 18F, MANTA 8F Depth Locator, MANTA 14F Depth Locator
- Applicant
- Teleflex Medical, LLC
- Applicant location
- Morrisville, NC
- Received
- Jan 13, 2023
- Decided
- Oct 11, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P180025
Device type
- Device type
- Device, hemostasis, vascular (MGB)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for an additional manufacturing site in Tecate, Mexico and an additional sterilization site (Sterigenics West Memphis, AR facility) for the subject device.
Source documents
Other decisions for Teleflex Medical, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262531 · Decided Oct 27, 2026 · 97 days after receipt
Device type: Instrument, Biopsy (KNW) · GI, Urology & Nephrology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.